• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕激素预处理卵巢刺激与轻度刺激方案在卵巢储备功能减退高龄患者行首次体外受精周期中的应用:一项回顾性队列研究。

Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First Fertilization Cycle: A Retrospective Cohort Study.

机构信息

Key Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Front Endocrinol (Lausanne). 2022 Jan 24;12:801026. doi: 10.3389/fendo.2021.801026. eCollection 2021.

DOI:10.3389/fendo.2021.801026
PMID:35140685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8818948/
Abstract

OBJECTIVE

To assess and compare the feasibility of progestin-primed ovarian stimulation (PPOS) protocol with mild stimulation protocol for advanced age women with diminished ovarian reserve (DOR) undergoing their first fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycle.

METHODS

Patients aged ≥35 years and DOR undergoing their first IVF/ICSI cycle were enrolled in this retrospective cohort study: 139 and 600 patients underwent the PPOS and mild stimulation protocols, respectively. The primary outcomes were cumulative clinical pregnancy rate (CCPR) and cumulative live birth rate (CLBR). The secondary outcomes were the number of oocytes retrieved and top-quality embryos.

RESULTS

There was nearly no significant difference of baseline characteristics between the two groups. Although a greater amount of total gonadotropin (1906.61 ± 631.04 IU vs. 997.72 ± 705.73 IU, <0.001) and longer duration of stimulation (9 (10-7) vs. 6 (8-4), <0.001) were observed in the PPOS group, the number of retrieved oocytes (3 (6-2) vs. 2 (4-1), <0.001) and top-quality embryos (1 (2-0) vs. 1 (2-0), =0.038) was greater in the PPOS group than the mild stimulation group. Meanwhile, the incidence of premature luteinizing hormone (LH) surge rate was significantly lower in the PPOS group (0.7% vs.8.3%, =0.001) than the mild stimulation group. However, there was no significant difference in conservative CCPR, conservative CLBR, optimistic CCPR, and optimistic CLBR between the two groups (all >0.05). A multivariate logistic regression model showed significant positive effects of the number of retrieved oocytes and number of top-quality embryos on conservative CCPR (OR=1.236, 95%CI: 1.048-1.456, =0.012, OR=2.313, 95%CI: 1.676-3.194, <0.001) and conservative CLBR (OR=1.250, 95%CI: 1.036-1.508, =0.020, OR=2.634, 95%CI: 1.799-3.857, <0.001) respectively, while significant negative effects of age were identified for conservative CCPR (OR=0.805, 95%CI: 0.739-0.877, <0.001) and conservative CLBR (OR=0.797, 95%CI: 0.723-0.879, <0.001).

CONCLUSION

The PPOS protocol is an effective alternative to the mild stimulation protocol for advanced age patients with DOR, as it provides comparable reproductive outcomes and better control of premature LH surge. Further, more oocytes and top-quality embryos were obtained in the PPOS group, which had a positive association with conservative CCPR and CLBR.

摘要

目的

评估和比较孕激素预处理卵巢刺激(PPOS)方案与轻度刺激方案在高龄伴有卵巢储备功能降低(DOR)的患者中进行首次体外受精(IVF)/卵胞浆内单精子注射(ICSI)周期的可行性。

方法

本回顾性队列研究纳入了年龄≥35 岁且 DOR 接受首次 IVF/ICSI 周期的患者:分别有 139 例和 600 例患者接受了 PPOS 和轻度刺激方案。主要结局是累积临床妊娠率(CCPR)和累积活产率(CLBR)。次要结局是获卵数和优质胚胎数。

结果

两组患者的基线特征几乎没有显著差异。尽管 PPOS 组使用了更多的总促性腺激素(1906.61±631.04IU 比 997.72±705.73IU,<0.001)和更长的刺激时间(9(10-7)比 6(8-4),<0.001),但 PPOS 组的获卵数(3(6-2)比 2(4-1),<0.001)和优质胚胎数(1(2-0)比 1(2-0),=0.038)更多。同时,PPOS 组的早发性黄体生成素(LH)峰发生率显著低于轻度刺激组(0.7%比 8.3%,=0.001)。然而,两组的保守性 CCPR、保守性 CLBR、乐观性 CCPR 和乐观性 CLBR 均无显著差异(均>0.05)。多变量逻辑回归模型显示,获卵数和优质胚胎数对保守性 CCPR(OR=1.236,95%CI:1.048-1.456,=0.012,OR=2.313,95%CI:1.676-3.194,<0.001)和保守性 CLBR(OR=1.250,95%CI:1.036-1.508,=0.020,OR=2.634,95%CI:1.799-3.857,<0.001)有显著的正效应,而年龄对保守性 CCPR(OR=0.805,95%CI:0.739-0.877,<0.001)和保守性 CLBR(OR=0.797,95%CI:0.723-0.879,<0.001)有显著的负效应。

结论

PPOS 方案是高龄伴有 DOR 患者的一种有效的轻度刺激方案替代方案,因为它提供了相似的生殖结局,并且更好地控制了早发性 LH 峰。此外,PPOS 组获得了更多的卵母细胞和优质胚胎,这与保守性 CCPR 和 CLBR 呈正相关。

相似文献

1
Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First Fertilization Cycle: A Retrospective Cohort Study.孕激素预处理卵巢刺激与轻度刺激方案在卵巢储备功能减退高龄患者行首次体外受精周期中的应用:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2022 Jan 24;12:801026. doi: 10.3389/fendo.2021.801026. eCollection 2021.
2
New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.地屈孕酮在 IVF 促性腺激素预备周期中的新应用:一项纳入 516 个首次 IVF/ICSI 周期的随机对照试验。
Hum Reprod. 2018 Feb 1;33(2):229-237. doi: 10.1093/humrep/dex367.
3
[Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].[每个取卵周期的累积活产率:体外受精/卵胞浆内单精子注射临床结局评估]
Zhonghua Fu Chan Ke Za Zhi. 2018 Mar 25;53(3):160-166. doi: 10.3760/cma.j.issn.0529-567X.2018.03.004.
4
Progestin-primed ovarian stimulation protocol with or without letrozole for patients with normal ovarian reserve: a retrospective cohort study.对卵巢储备功能正常的患者采用孕激素预处理的卵巢刺激方案联合或不联合来曲唑:一项回顾性队列研究
J Clin Pharm Ther. 2022 Apr;47(4):469-476. doi: 10.1111/jcpt.13567. Epub 2021 Nov 18.
5
Benefit from luteal phase progestin primed ovarian stimulation with clomiphene citrate supplementation in young women with diminished ovarian reserve: a retrospective study.在卵巢储备功能减退的年轻妇女中,使用枸橼酸氯米酚补充黄体期孕激素预刺激:一项回顾性研究。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 May 16;53(3):297-305. doi: 10.3724/zdxbyxb-2023-0533.
6
Progestin-primed ovarian stimulation with letrozole using different doses of medroxyprogesterone acetate per day: a retrospective cohort study.来曲唑联合不同剂量醋酸甲羟孕酮行孕激素预处理的卵巢刺激方案:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2024 Jul 12;15:1429338. doi: 10.3389/fendo.2024.1429338. eCollection 2024.
7
Progestin-Primed Ovarian Stimulation with Clomiphene Citrate Supplementation May Be More Feasible for Young Women with Diminished Ovarian Reserve Compared with Standard Progestin-Primed Ovarian Stimulation: A Retrospective Study.枸橼酸氯米酚预处理加孕激素的卵巢刺激可能比标准孕激素预处理的卵巢刺激更适用于卵巢储备功能减退的年轻女性:一项回顾性研究。
Drug Des Devel Ther. 2021 Dec 21;15:5087-5097. doi: 10.2147/DDDT.S338748. eCollection 2021.
8
The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study.孕激素预处理促排卵方案中醋酸甲羟孕酮固定剂量与递减剂量联合来曲唑的比较:一项倾向评分匹配研究。
Front Endocrinol (Lausanne). 2023 Dec 12;14:1295787. doi: 10.3389/fendo.2023.1295787. eCollection 2023.
9
Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.多囊卵巢综合征患者中采用灵活 GnRH 拮抗剂方案与孕激素预刺激卵巢刺激(PPOS)方案:临床结局和卵巢反应的比较。
Curr Med Sci. 2019 Jun;39(3):431-436. doi: 10.1007/s11596-019-2055-x. Epub 2019 Jun 17.
10
Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.根据 POSEIDON 标准,低预后患者中 GnRH-A 与 PPOS 累积活产率的比较:一项队列研究。
Front Endocrinol (Lausanne). 2021 Jun 21;12:644456. doi: 10.3389/fendo.2021.644456. eCollection 2021.

引用本文的文献

1
The impact of different ovarian stimulation protocols on the expression levels of GDF-9 and BMP-15 in cumulus cells of follicles.不同卵巢刺激方案对卵泡卵丘细胞中GDF-9和BMP-15表达水平的影响。
Front Endocrinol (Lausanne). 2025 Jun 4;16:1572388. doi: 10.3389/fendo.2025.1572388. eCollection 2025.
2
Analysis of cumulative live birth rate outcomes of four ovarian stimulation protocols in Poseidon groups 3/4 patients with adenomyosis.波塞冬3/4组子宫腺肌病患者四种卵巢刺激方案的累积活产率结果分析
J Assist Reprod Genet. 2025 May 9. doi: 10.1007/s10815-025-03488-4.
3
Effect of letrozole cotreatment in progestin-primed ovarian stimulation on IVF/ICSI outcomes in POSEIDON group 3 and 4 poor responders: a retrospective cohort study.来曲唑联合治疗在孕激素预处理的卵巢刺激中对波塞冬3组和4组低反应者体外受精/卵胞浆内单精子注射结局的影响:一项回顾性队列研究
Eur J Med Res. 2025 Apr 22;30(1):314. doi: 10.1186/s40001-025-02393-x.
4
The application of progesterone-primed ovarian stimulation protocol in patients with ovarian endometriosis combined with diminished ovarian reserve.孕激素预处理卵巢刺激方案在卵巢子宫内膜异位症合并卵巢储备功能减退患者中的应用
BMC Womens Health. 2025 Feb 18;25(1):70. doi: 10.1186/s12905-025-03601-w.
5
Development and validation of a nomogram for failure to collect oocytes in POSEIDON Groups 3 and 4 undergoing IVF/ICSI treatment.用于预测接受体外受精/卵胞浆内单精子注射治疗的波塞冬3组和4组中未采集到卵母细胞的列线图的开发与验证
Sci Rep. 2024 Dec 28;14(1):31316. doi: 10.1038/s41598-024-82783-z.
6
Progesterone Primed Ovarian Stimulation (PPOS) vs. clomiphene Primed Ovarian Stimulation (CPOS) in high responder (HR) patients undergoing controlled ovarian stimulation. A Randomised Control trial.在接受控制性卵巢刺激的高反应者(HR)患者中,孕酮预处理卵巢刺激(PPOS)与克罗米芬预处理卵巢刺激(CPOS)的比较。一项随机对照试验。
JBRA Assist Reprod. 2025 Mar 12;29(1):21-26. doi: 10.5935/1518-0557.20240083.
7
Progestin-primed ovarian stimulation with letrozole using different doses of medroxyprogesterone acetate per day: a retrospective cohort study.来曲唑联合不同剂量醋酸甲羟孕酮行孕激素预处理的卵巢刺激方案:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2024 Jul 12;15:1429338. doi: 10.3389/fendo.2024.1429338. eCollection 2024.
8
Benefit from luteal phase progestin primed ovarian stimulation with clomiphene citrate supplementation in young women with diminished ovarian reserve: a retrospective study.在卵巢储备功能减退的年轻妇女中,使用枸橼酸氯米酚补充黄体期孕激素预刺激:一项回顾性研究。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 May 16;53(3):297-305. doi: 10.3724/zdxbyxb-2023-0533.
9
Effect of medroxyprogesterone acetate dose in progestin-primed ovarian stimulation on pregnancy outcomes in poor ovarian response patients with different body mass index levels.醋酸甲羟孕酮剂量在孕激素预处理卵巢刺激中对不同体重指数水平的卵巢反应不良患者妊娠结局的影响。
Front Endocrinol (Lausanne). 2024 Apr 18;15:1352522. doi: 10.3389/fendo.2024.1352522. eCollection 2024.
10
Implications of Progestin-Primed Ovarian Stimulation (PPOS) in a Patient With Diminished Ovarian Reserve (DOR) and Its In Vitro Fertilization (IVF) Outcome.孕激素预处理卵巢刺激(PPOS)对卵巢储备功能减退(DOR)患者的影响及其体外受精(IVF)结局
Cureus. 2024 Feb 23;16(2):e54743. doi: 10.7759/cureus.54743. eCollection 2024 Feb.

本文引用的文献

1
Cumulative live birth rates do not increase after 4 complete cycles in women with poor ovarian response: a retrospective study of 1,825 patients.卵巢反应不良女性在4个完整周期后累积活产率并未增加:一项对1825例患者的回顾性研究。
F S Rep. 2021 Feb 2;2(2):201-208. doi: 10.1016/j.xfre.2021.01.004. eCollection 2021 Jun.
2
Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis.轻度与常规卵巢刺激方案在卵巢低反应、正常反应和高反应人群中行体外受精的比较:一项系统评价和荟萃分析。
Hum Reprod Update. 2021 Feb 19;27(2):229-253. doi: 10.1093/humupd/dmaa035.
3
Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses.辅助生殖技术卵巢刺激期间用于垂体抑制的孕激素:一项包括荟萃分析的全面系统评价
Hum Reprod Update. 2021 Jan 4;27(1):48-66. doi: 10.1093/humupd/dmaa040.
4
Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing Fertilization Treatment: A Randomized Controlled Trial.孕激素与促性腺激素释放激素拮抗剂预防低反应者体外受精治疗中过早促黄体生成素峰的随机对照试验
Front Endocrinol (Lausanne). 2019 Nov 22;10:796. doi: 10.3389/fendo.2019.00796. eCollection 2019.
5
Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study.孕激素预处理卵巢刺激与高龄(40 岁以上)妇女轻度刺激的比较:一项回顾性队列研究。
Reprod Biol Endocrinol. 2019 Nov 9;17(1):91. doi: 10.1186/s12958-019-0518-3.
6
Progestin-primed ovarian stimulation improves the outcomes of IVF/ICSI cycles in infertile women with diminished ovarian reserve.孕激素预处理可改善卵巢储备功能减退不孕患者 IVF/ICSI 周期的结局。
J Chin Med Assoc. 2019 Nov;82(11):845-848. doi: 10.1097/JCMA.0000000000000177.
7
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?在卵巢刺激过程中使用孕激素抑制自发性排卵:新时代的开始?
Reprod Biomed Online. 2019 Aug;39(2):321-331. doi: 10.1016/j.rbmo.2019.03.212. Epub 2019 Mar 29.
8
Cumulative live birth rates in low-prognosis women.低预后女性的累积活产率。
Hum Reprod. 2019 Jun 4;34(6):1030-1041. doi: 10.1093/humrep/dez051.
9
Ovarian ageing and the impact on female fertility.卵巢衰老及其对女性生育能力的影响。
F1000Res. 2018 Nov 22;7. doi: 10.12688/f1000research.16509.1. eCollection 2018.
10
Cumulative live birth rates and number of oocytes retrieved in women of advanced age. A single centre analysis including 4500 women ≥38 years old.高龄妇女的累积活产率和取卵数。包括 4500 名≥38 岁妇女的单个中心分析。
Hum Reprod. 2018 Nov 1;33(11):2010-2017. doi: 10.1093/humrep/dey295.